Ljunggren H G, Kärre K
J Exp Med. 1985 Dec 1;162(6):1745-59. doi: 10.1084/jem.162.6.1745.
Three independent variants with a profound reduction of cell surface H-2 have been selected from the C57BL/6 mouse-derived RBL-5 and EL-4 T lymphomas. After subcutaneous inoculation of low cell doses in syngeneic mice, the H-2- variants failed to grow out, whereas the H-2+ control lines showed progressive growth. No difference in growth rate or cloning efficiency was detectable in tissue culture. The in vivo difference in tumor outgrowth was analyzed in detail for one of the H-2-low lines. The outgrowth difference remained after the H-2-low variant and the control line had been injected subcutaneously in opposite flanks of the same mouse, and it was not dependent upon activity of mature T cells, since the same result was seen in athymic nude mice. The difference was partially sensitive to irradiation of the hosts. When mice were pretreated with anti-asialo GM1 antiserum, known to depress natural killer (NK) cell activity, the difference in outgrowth was abolished, and both the control line and the H-2- variant showed progressive growth in vivo. Experiments comparing the distribution and survival of isotope-prelabeled variant and wild type cells indicated that a rapid elimination of the former took place within 24 h after intravenous injection. These differences in tumor elimination were not seen in mice treated with anti-asialo GM1 antiserum. We conclude that the reduced tumorigenicity of sublines with impaired H-2 expression is largely, if not exclusively due to rapid elimination by NK cells. These findings may reflect an inverse, indirect relation between factors controlling H-2 expression and NK sensitivity. Another possible explanation is that major histocompatibility complex (MHC)-encoded gene products are directly involved in a regulatory signal in the NK cell system. According to this interpretation, immunological selectivity in the NK cell system would be achieved by the failure to recognize self-MHC, irrespective of the presence of foreign antigens, i.e. by detection of no-self rather than of nonself. This may also explain previous observations on H-2-linked hybrid resistance against lymphoid grafts and changes in H-2 phenotypes associated with tumor progression.
已从源自C57BL/6小鼠的RBL-5和EL-4 T淋巴瘤中筛选出三种细胞表面H-2显著减少的独立变体。在同基因小鼠中皮下接种低细胞剂量后,H-2变体无法生长,而H-2+对照系则呈进行性生长。在组织培养中未检测到生长速率或克隆效率的差异。对其中一个H-2低表达系的肿瘤生长体内差异进行了详细分析。在同一小鼠的相对侧翼皮下注射H-2低表达变体和对照系后,生长差异仍然存在,并且不依赖于成熟T细胞的活性,因为在无胸腺裸鼠中也观察到了相同的结果。这种差异对宿主的辐射部分敏感。当用已知可抑制自然杀伤(NK)细胞活性的抗唾液酸GM1抗血清预处理小鼠时,生长差异消失,对照系和H-2变体在体内均呈进行性生长。比较同位素预标记变体和野生型细胞的分布和存活情况的实验表明,前者在静脉注射后24小时内迅速被清除。在用抗唾液酸GM1抗血清处理的小鼠中未观察到这些肿瘤清除差异。我们得出结论,H-2表达受损的亚系致瘤性降低,如果不是完全归因于NK细胞的快速清除,也在很大程度上是由于NK细胞的快速清除。这些发现可能反映了控制H-2表达的因素与NK敏感性之间的反向、间接关系。另一种可能的解释是,主要组织相容性复合体(MHC)编码的基因产物直接参与NK细胞系统的调节信号。根据这种解释,NK细胞系统中的免疫选择性将通过无法识别自身MHC来实现,而与外来抗原的存在无关,即通过检测非自身而非异己。这也可能解释了先前关于H-2连锁的针对淋巴样移植物的杂种抗性以及与肿瘤进展相关的H-2表型变化的观察结果。